4//SEC Filing
Rendall David 4
Accession 0001209191-21-043164
CIK 0001006028other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 7:36 PM ET
Size
5.7 KB
Accession
0001209191-21-043164
Insider Transaction Report
Form 4
Rendall David
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-18+100,000→ 100,000 totalExercise: $0.45Exp: 2031-06-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001869521
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 7:36 PM ET
- Size
- 5.7 KB